INBX · Inhibrx Biosciences, Inc. · Proposed Sales
$87.75
-2.85 (-3.14%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$1.29B
Shares
14.72M
Volume · Nov 12
226.49K
Avg daily vol (3M)
305.28K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-15 | MANHARD KIMBERLY | Director | 500 | 2026-09-15 | Fidelity Brokerage Services LLC |
| 2026-09-14 | MANHARD KIMBERLY | Director | 500 | 2026-09-14 | Fidelity Brokerage Services LLC |
| 2026-09-11 | MANHARD KIMBERLY | Director | 500 | 2026-09-11 | Fidelity Brokerage Services LLC |
| 2026-09-09 | MANHARD KIMBERLY | Director | 500 | 2026-09-09 | Fidelity Brokerage Services LLC |
| 2026-09-08 | MANHARD KIMBERLY | Director | 500 | 2026-09-08 | Fidelity Brokerage Services LLC |
Showing 1–5 of 5 filings
Key facts
CIK
2007919
CUSIP
45720N103
13F (30d)
88 filings
84 filers
Visit website
Investor relations